Brief: Ventripoint Receives Market Clearance From U.S. FDA For Complete Heart Analysis System Using 2D Ultrasound
16/05/2018 13:43
May 16 (Reuters) - VentriPoint Diagnostics Ltd VPT.V :
* VENTRIPOINT RECEIVES MARKET CLEARANCE FROM US-FDA FOR
COMPLETE
HEART ANALYSIS SYSTEM USING 2D ULTRASOUND
Source text for Eikon: ID:nGNX33Xwlm
Further company coverage: VPT.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VentriPoint Diagnostics
See all newsBrief: Ventripoint Receives Market Clearance From U.S. FDA For Complete Heart Analysis System Using 2D Ultrasound
Brief: Ventripoint Diagnostics says expecting marketing clearance for 4-chamber VMS in early 2018
Brief: Ventripoint announces increase in size of private placement
Brief: Ventripoint announces $2,000,000 non-brokered private placement
Brief: Ventripoint Diagnostics announces filing of application for complete heart analysis system with Health Canada